Biogen Alzheimer’s drug and the battle over dementia treatment of the future

Biogen Alzheimer’s drug Aduhelm is the first new treatment for dementia approved by the FDA in decades, and it’s started a war over the brain drug pipeline.

Health, Fitness & Food

Products You May Like

Articles You May Like

Get vaccinated or fired — Ken Langone says his businesses will mandate it after full FDA approval
Royal Caribbean shares tumble as 6 Covid cases discovered on board a ship, cruise line expands U.S. testing policy
California is requiring proof of Covid vaccination for state employees, predicting significant rise in hospitalizations
CDC study shows 74% of people infected in Massachusetts Covid outbreak were fully vaccinated
CDC reverses indoor mask policy, saying fully vaccinated people and kids should wear them indoors

Leave a Reply

Your email address will not be published. Required fields are marked *